Bar-Peled, Liron http://orcid.org/0000-0003-2687-9546
Kory, Nora http://orcid.org/0000-0001-5307-9021
Article History
Received: 30 March 2022
Accepted: 24 August 2022
First Online: 20 October 2022
Competing interests
: N.K. is funded by National Institutes of Health (NIH) R00 ExternalRef removed and the Damon Runyon Cancer Research Foundation (73-22). L.B.-P. is funded by the Damon Runyon Cancer Research Foundation (62-20), the American Association for Cancer Research (19-20-45-BARP), the American Cancer Society, the Melanoma Research Alliance, the Ludwig Cancer Center of Harvard Medical School, Lungevity, ALK Positive, V-Foundation, Mary Kay Foundation, Paula and Rodger Riney Foundation and the NIH/National Cancer Institute (1R21CA226082-01, R37CA260062). L.B-P. is a founder and consultant of and holds privately held equity in Scorpion Therapeutics.